Clinical Trials Validation, 21 CFR Part 11 Compliance

Slides:



Advertisements
Similar presentations
PRINCIPLES OF A CALIBRATION MANAGEMENT SYSTEM
Advertisements

Radiopharmaceutical Production
Introduction to Records Management Policy
VALIDATION OF COMPUTERISED SYSTEMS IN THE PHARMACEUTICAL INDUSTRY Matt Safi Product manager.
Health Insurance Portability and Accountability Act (HIPAA)HIPAA.
THE UW HEALTH SCIENCES IRB S OVERVIEW PRACTICAL REGULATORY ISSUES IN HUMAN SUBJECTS RESEARCH.
SOP Melody Lin, Ph.D. Deputy Director, Office for Human Research Protections Director, International Activities Santiago, Chile August.
The Institutional Review Board. What is an IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
Audit of IT Systems SARQA / DKG Scandinavian Conference, October 2002, Copenhagen Sue Gregory.
Regulatory Compliant Performance Improvement for Pharmaceutical Plants AIChE New Jersey Section 01/13/2004 Murugan Govindasamy Pfizer Inc.
Phone: (919) Fax: (919) CFR Part 11 FDA Public Meeting Comments Presented by: M. Rita.
Cheryl McCarthy Manager, Quality Assurance MBC Session October 3, 2008 GCP Compliance in our Vendors.
MFRPS Lesson Learned North Carolina
Coping with Electronic Records Setting Standards for Private Sector E-records Retention.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
NIH Proposed Use of a Central IRB (C-IRB) for NIH-funded multi-site studies Committee on Clinical Research January 26,
FAMILY EDUCATIONAL RIGHTS AND PRIVACY ACT Electronic Signatures This work is the intellectual property of the author. Permission is granted for this material.
CDRH Software Regulation
Session 6: Data Integrity and Inspection of e-Clinical Computerized Systems May 15, 2011 | Beijing, China Kim Nitahara Principal Consultant and CEO META.
Title 21 Code of Federal Regulations 21CFR Part 11
An introduction to CDISC and CDASH Bring on the Standards! Emmanuelle Denis M.Sc., MICR Global Health Clinical Trials Research Programme.
11/2/991 CDER’s 21 CFR Part 11 Implementation Study Greg Brolund Associate Director, Office of Information Technology, CDER/FDA.
Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum 21 CFR Part 11 Considerations November 14, 2002.
21 CFR Part 11 A Food Industry Perspective FDA Public Meeting June 11, 2004 Sia Economides Center Director Center for Development of Research Policy and.
DRAFT Richard Chandler-Mant – R Consultant The Challenges of Validating R Managing R in a Commercial Environment.
Project co-financed by European Union Project co- financed by Asean European Committee for Standardization Implementing Agency1 GMP Workshop Kuala Lumpur.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
Ruth Carrico PhD RN FSHEA CIC Associate Professor Division of Infectious Diseases.
STUDY CLOSE OUT KEMRI-Wellcome Trust Research Programme Version: 4-Nov-2008.
Case Study: Pharmaceuticals Patrick F. Sullivan, Ph.D. 939 North Graham Avenue, Indianapolis, IN
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Compliance with FDA Regulations: Collecting, Transmitting and Managing Clinical Information Dan C Pettus Senior Vice President iMetrikus, Inc.
Legal & Ethical Issues. Objectives At the completion of this session the participant will be able to: ◦ Describe the ethical principles associated with.
Eliza de Guzman HTM 520 Health Information Exchange.
The IT Quality Assurance FDA Validation Specialists Phone: 877-MGD-TEST ( ) n n n n Web Site:
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
FDA Public Meeting on Electronic Records and Signatures June 11, 2004 Presentation of the Industry Coalition on 21CFR Part 11 Alan Goldhammer, PhD Chair.
This class cannot be shared or copied without the written permission of PracticeWorks Systems, LLC.
Part 11, Electronic Records; Electronic Signatures
Integrating a Federated Healthcare Data Query Platform With Electronic IRB Information Systems Shan He IPHIE 2010.
Module C FDA Regulations Regulatory Documents Patricia E. Koziol 1Module C Final Version 10-apr-2010.
Part 11 Public Meeting PEERS Questions & Responses The opinions expressed here belong to PEERS members and not the corporate entities with which they are.
The world leader in serving science Validation and Qualification Overview Mike Garry Software Product Manager Spectroscopy Software Platform Team.
FDA Part 11 Public Meeting Washington, DC June 11, 2004 Paul D’Eramo Executive Director Worldwide Policy & Compliance Management Quality & Compliance Services.
© 2004, Genentech Electronic Records; Electronic Signatures Public Meeting Docket No. 2004N-0133 Kenneth Kornfield, Associate Director, Global Quality.
Information Resource Stewardship A suggested approach for managing the critical information assets of the organization.
The world leader in serving science OMNIC DS & Thermo Security Administration 21 CFR Part 11 Tools for FT-IR and Raman Spectroscopy.
InstantGMP MD/PRO Electronic Device History File Software for Manufacturing Medical Devices in compliance with 21 CFR Part 820 (Quality System Regulation)
The CDRH Software Message (October 19, 2002) John F Murray Jr.. Center for Devices & Radiological Health US Food and Drug Administration
SEMINAR ON, PRESENTED BY, POONAM Y AGHARA M – PHARM DEPT. OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLOGY L. M. COLLEGE OF PHARMACY AHMEDABAD.
InfoSecurity Compliance Are you ready to be regulated? Presented by: Umesh Verma CEO, BLUE LANCE
© 2016 Chapter 6 Data Management Health Information Management Technology: An Applied Approach.
Junli M. Awit, RN.  Enacted by President Bill Clinton in 1996  Title I of HIPAA protects health insurance coverage for workers and their families when.
21 CFR PART 11.
FDA 21 CFR Part 11 Compliance
Study Closure What Happens Next?
Overview eSignature Features: Field Type vs Record Locking Regulations
Lisa Hoebelheinrich, JD, CHRC Associate Vice Chancellor, Compliance
Stephanie Oppenheimer, MS SUCCESS Center Erica Ellington, CRA, CHRC
Ensuring Nuclear Safety Culture in Ghana: Regulatory Perspective
REDCap Regulatory Binder
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
בקרה תוך שימוש ב 21CFR Part 11 / אילן שעיה סמארט לוג'יק
FDA 21 CFR Part 11 Overview June 10, 2006.
Making Your IRBs and Clinical Investigators HIPAA-Ready
Understanding the Process of Documenting Informed Consent
Computer System Validation
Radiopharmaceutical Production
Research with Human Subjects
Presentation transcript:

Clinical Trials Validation, 21 CFR Part 11 Compliance By: Terri Shkuda Kim Gajewski Sam Walkow

Introduction Validation Definition Validation Goal The process of testing and the documentation of that testing Validation Goal To verify that system functions work as intended Who should validate? Any instance hosting clinical trials Any organization with a validation policy

Regulatory & System Validation System validation allows for an institution to earn the trust of the researchers so that their data will be protected and documented evidence will be available to prove that the system was developed, implemented and operated in a controlled manner throughout the life cycle of the system. The driving forces for validation are to ensure that human subject data is protected, risk is reduced, data is secure and the system is available. System validation is useful on a global scale, however you would need to tailor the validation to your own government agency’s requirements. For example, US Government regulations that are addressed: HIPAA 21 CFR Part 11

21 CFR Part 11 Title 21 of the Code of Federal Regulations for the U.S.: Electronic Records; Electronic Signature (21 CFR Part 11) In order to submit information to the Food and Drug Administration (FDA), researchers need to show compliance with 21 CFR Part 11. In particular, it “….applies to electronic records that are created, modified, maintained, archived, retrieved or transmitted...”1 Validating the REDCap system serves as only part of this compliance picture. The project’s study team will need to provide documentation of their processes as well to show compliance. The REDCap application can be only considered 21 CFR Part 11 capable. 1http://www.fda.gov/RegulatoryInformation/Guidances/ucm125067.htm#i

Study + System = Part 11 Compliance Research Project Team Study SOPs Data Management Plan Administrative Controls Technical Controls Physical Controls Study Team Processes Software Development Life Cycle Institution’s System Validation

REDCap Consortium’s Regulatory & Software Validation Committee The REDCap Regulatory & Software Validation committee, provides documentation to support system validation, HIPAA and 21 CFR Part 11 compliance. It provides the Functional Specification with its corresponding core validation test scripts to support your own validation activities. Duke University has shared their Validation SOPs which are posted on the Community site. The committee also provides a document on the community site that addresses 21 CFR Part 11 predicate rules as well as FAQs.